Skip to content

Drug interactions

Bortezomib + Fedratinib

Severity: Minor

Bortezomib and Fedratinib: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Fedratinib is metabolized by CYP3A4 and CYP2C19, and bortezomib is not a clinically established potent dual inhibitor of these enzymes. The legacy concern is therefore not well supported by known pharmacology. Both drugs can cause gastrointestinal toxicity and cytopenias, but no specific pharmacokinetic interaction is established.

What this interaction means in plain words

Bortezomib and Fedratinib have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Bortezomib belongs to Oncology; Fedratinib belongs to Oncology.

Evidence level: Low

Why it happens

No established pharmacokinetic mechanism; the interaction is theoretical.

What to do

No dose adjustment is needed. Monitor blood counts and neurologic status as routine.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Bortezomib and Fedratinib, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Bortezomib with Fedratinib?

MediHelp rates the interaction as minor. Bortezomib and Fedratinib have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Fedratinib is metabolized by CYP3A4 and CYP2C19, and bortezomib is not a clinically established potent dual inhibitor of these enzymes. The legacy concern is therefore not well supported by known pharmacology. Both drugs can cause gastrointestinal toxicity and cytopenias, but no specific pharmacokinetic interaction is established.

How serious is the interaction between Bortezomib and Fedratinib?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: No dose adjustment is needed. Monitor blood counts and neurologic status as routine.

What other medicines interact with Bortezomib?

MediHelp also lists interactions of Bortezomib with, for example, Apalutamide, Carbamazepine, Etrasimod. The full list is on the Bortezomib page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in